A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.
作者信息
Goetz Lianna, Yang Jianbo, Greene Wallace, Zhu Yusheng
机构信息
Department of Pathology and Laboratory Medicine, Pennsylvania State University College of Medicine, Hershey, PA.
出版信息
J Appl Lab Med. 2020 Nov 1;5(6):1401-1405. doi: 10.1093/jalm/jfaa137.
Abstract
摘要
相似文献
1
A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.一名严重急性呼吸综合征冠状病毒2（SARS-CoV-2）抗体多次检测不到的新型冠状病毒肺炎（COVID-19）患者。
J Appl Lab Med. 2020 Nov 1;5(6):1401-1405. doi: 10.1093/jalm/jfaa137.
2
Cross-Comparison of a Chemiluminescent Platform and a Commercial Receptor Binding Domain-Based ELISA for Detecting SARS-CoV-2 IgG.用于检测新型冠状病毒2型免疫球蛋白G的化学发光平台与基于商业受体结合域的酶联免疫吸附测定的交叉比较
J Appl Lab Med. 2020 Nov 1;5(6):1416-1420. doi: 10.1093/jalm/jfaa133.
3
Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays.两种严重急性呼吸综合征冠状病毒2血清学检测方法的直接比较
J Appl Lab Med. 2020 Nov 1;5(6):1351-1357. doi: 10.1093/jalm/jfaa125.
4
Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic.2019冠状病毒病大流行期间24例出现冻疮样病变患者的严重急性呼吸综合征冠状病毒2抗体评估
J Am Acad Dermatol. 2020 Dec;83(6):1753-1755. doi: 10.1016/j.jaad.2020.08.049. Epub 2020 Aug 18.
5
Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay.一种电化学发光SARS-CoV-2抗体检测方法的评估
J Appl Lab Med. 2020 Nov 1;5(6):1313-1323. doi: 10.1093/jalm/jfaa134.
6
Analysis of adjunctive serological detection to nucleic acid test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection diagnosis.分析辅助血清学检测在严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染诊断中的应用。
Int Immunopharmacol. 2020 Sep;86:106746. doi: 10.1016/j.intimp.2020.106746. Epub 2020 Jun 26.
7
Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19.用于检测新型冠状病毒肺炎的严重急性呼吸综合征冠状病毒2血清学检测方法的多平台比较
J Appl Lab Med. 2020 Nov 1;5(6):1324-1336. doi: 10.1093/jalm/jfaa139.
8
Chilblain-like lesions during the COVID-19 pandemic: a serological study on a case series.2019冠状病毒病大流行期间的冻疮样病变：一项病例系列血清学研究
Br J Dermatol. 2020 Oct;183(4):782-784. doi: 10.1111/bjd.19348. Epub 2020 Jul 28.
9
Covid-19 antibody tests: a briefing.新冠病毒-19抗体检测：简报
BMJ. 2020 Jun 24;369:m2284. doi: 10.1136/bmj.m2284.
10
Interpreting Diagnostic Tests for SARS-CoV-2.解读新型冠状病毒2019（SARS-CoV-2）诊断检测结果
JAMA. 2020 Jun 9;323(22):2249-2251. doi: 10.1001/jama.2020.8259.
引用本文的文献
1
Evaluation of ten (10) SARS-CoV-2 rapid serological tests in comparison with WANTAI SARS-CoV-2 ab ELISA in Burkina Faso, West Africa.评估十种（10）种 SARS-CoV-2 快速血清学检测试剂在西非布基纳法索与万泰 SARS-CoV-2 ab ELISA 的比较。
Virol J. 2023 Mar 30;20(1):57. doi: 10.1186/s12985-023-02011-4.
2
Venetoclax Decreases the Expression of the Spike Protein through Amino Acids Q493 and S494 in SARS-CoV-2.维奈托克通过 SARS-CoV-2 的氨基酸 Q493 和 S494 降低刺突蛋白的表达。
Cells. 2022 Jun 14;11(12):1924. doi: 10.3390/cells11121924.
3
Preoperative assessment for scheduling surgery during the coronavirus disease pandemic.新冠肺炎疫情期间手术安排的术前评估。
J Anesth. 2021 Jun;35(3):378-383. doi: 10.1007/s00540-021-02896-x. Epub 2021 Jan 27.
4
COVID-19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies?COVID-19 治疗采用间充质基质细胞（MSC）和恢复期血浆必须考虑外泌体的参与：恢复期血浆中的外泌体是否拮抗了微弱的免疫抗体？
J Extracell Vesicles. 2020 Oct;10(1):e12004. doi: 10.1002/jev2.12004. Epub 2020 Nov 14.
5
Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency.SARS-CoV-2 大流行对原发性免疫缺陷患者的影响。
J Clin Immunol. 2021 Feb;41(2):345-355. doi: 10.1007/s10875-020-00928-x. Epub 2020 Dec 1.
6
Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies.抗新型冠状病毒2抗体检测的特异性和交叉反应性
Lancet Infect Dis. 2021 May;21(5):e118. doi: 10.1016/S1473-3099(20)30787-8. Epub 2020 Oct 30.
7
Serological assays for delayed SARS-CoV-2 case identification.用于延迟识别新型冠状病毒2型病例的血清学检测
Lancet Respir Med. 2020 Oct;8(10):e73. doi: 10.1016/S2213-2600(20)30409-4. Epub 2020 Sep 14.
Zotero 插件